DeRoyal is a well-established global medical manufacturer that has been in operation since 1973. With a workforce of 1,900 employees spread across 20 facility locations in 5 countries and manufacturing assets on 2 continents, the company has a strong global presence. DeRoyal offers a wide range of products and business solutions, including patient care products, orthopedic supports & bracing, surgical & safety devices, wound care products, and Continuum® integrated inventory management technologies. The company is committed to improving the clinical quality and economic health of its customers. DeRoyal's ability to combine fundamental manufacturing capabilities with unique services and information technology tools enables them to deliver unparalleled quality and value to their customers. Their diverse portfolio of over 25,000 different products is a testament to their commitment to innovation and addressing the needs of clinicians and patients. As a company operating in the Consumer Goods, Health Care, and Manufacturing industries, DeRoyal has demonstrated resilience and adaptability over its 50-year history, positioning itself as a key player in the global medical manufacturing sector. Despite its impressive track record, details regarding DeRoyal's last investment and the associated investors are currently unavailable. However, given its strong market presence and extensive product portfolio, DeRoyal presents itself as a compelling investment opportunity for venture capital firms seeking exposure to the healthcare and manufacturing sectors. With its motto "Improving Care. Improving Business." DeRoyal exemplifies a commitment to delivering innovative solutions that benefit both its customers and its business operations.
There is no investment information
No recent news or press coverage available for DeRoyal.